Hey I didn’t finish my thought but ultimately MF should be in the business to unlock value for shareholders and I do wish he will do that everyone who’s invested
I know licensing is the quickest route to market for a company this size with the kind of capital needed. Fda could ask for more trials if so could revive afford it?